[TOKYO] Novartis AG appointed Vasant Narasimhan, the company’s global head of drug development, to take over from Joseph Jimenez as chief executive officer early next year.
Mr Narasimhan, who is also the chief medical officer of the drugmaker, will take over the reins from Feb 1, Novartis...
https://goo.gl/nKa3gu
Monday, 4 September 2017
Novartis names Narasimhan CEO to replace Jimenez next year, Consumer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment